Trial intelligence / Profile preview

Sitagliptin Effect on Macronutrient Hormonal Response

NCT00885638Phase 4Completed

Sponsor
Lund University
Start
Aug 2009
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Lund University. Primary endpoint: Glucagon-like Peptide-1 Secretion After Meal Ingestion. Started Aug 2009; status: completed.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00885638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00885638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call